Cargando…
Mechanisms and Effects of a WeChat-Based Intervention on Suicide Among People Living With HIV and Depression: Path Model Analysis of a Randomized Controlled Trial
BACKGROUND: People living with HIV and depression have high rates of suicide. Studies of mobile health (mHealth) interventions have shown feasibility, acceptability, and efficacy in improving mental health in people living with HIV and depression. However, few studies have examined the mechanisms an...
Autores principales: | Li, Yiran, Guo, Yan, Hong, Y Alicia, Zhu, Mengting, Zeng, Chengbo, Qiao, Jiaying, Xu, Zhimeng, Zhang, Hanxi, Zeng, Yu, Cai, Weiping, Li, Linghua, Liu, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906623/ https://www.ncbi.nlm.nih.gov/pubmed/31774411 http://dx.doi.org/10.2196/14729 |
Ejemplares similares
-
Effect of a WeChat-Based Intervention (Run4Love) on Depressive Symptoms Among People Living With HIV in China: Randomized Controlled Trial
por: Guo, Yan, et al.
Publicado: (2020) -
Run4Love, a mHealth (WeChat-based) intervention to improve mental health of people living with HIV: a randomized controlled trial protocol
por: Guo, Yan, et al.
Publicado: (2018) -
Development and Feasibility Testing of an mHealth (Text Message and WeChat) Intervention to Improve the Medication Adherence and Quality of Life of People Living with HIV in China: Pilot Randomized Controlled Trial
por: Guo, Yan, et al.
Publicado: (2018) -
Mediators of Intervention Effects on Depressive Symptoms Among People Living With HIV: Secondary Analysis of a Mobile Health Randomized Controlled Trial Using Latent Growth Curve Modeling
por: Zhu, Mengting, et al.
Publicado: (2019) -
Mediating Effects of Stigma and Depressive Symptoms in a Social Media–Based Intervention to Improve Long-term Quality of Life Among People Living With HIV: Secondary Analysis of a Randomized Controlled Trial
por: Li, Yiran, et al.
Publicado: (2021)